{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:42Z","timestamp":1772165742944,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Public Welfare Research Project","award":["201402010"],"award-info":[{"award-number":["201402010"]}]},{"name":"the Thousand-Hundred-Ten Talent Project of Guangxi Province","award":["2015226"],"award-info":[{"award-number":["2015226"]}]},{"name":"the 139 Medical High-level Talents Training Plan of Guangxi Province","award":["G201903032"],"award-info":[{"award-number":["G201903032"]}]},{"name":"the Guangxi Medical Hygiene Appropriate Technology Development and Application Project","award":["S2018031"],"award-info":[{"award-number":["S2018031"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To study the risk factors involved in the occurrence and progression of cervical intraepithelial neoplasia (CIN) and to establish predictive models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Genemania was used to build a gene network. Then, the core gene-related pathways associated with the occurrence and progression of CIN were screened in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Real-time fluorescence quantitative polymerase chain reaction (RT-qPCR) experiments were performed to verify the differential expression of the identified genes in different tissues. R language was used for predictive model establishment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 10 genes were investigated in this study. A total of 30 cases of cervical squamous cell cancer (SCC), 52 cases of CIN and 38 cases of normal cervix were enrolled. Compared to CIN cases, the age of patients in the SCC group was older, the number of parities was greater, and the percentage of patients diagnosed with CINII+ by TCT was higher. The expression of TGFBR2, CSKN1A1, PRKCI and CTBP2 was significantly higher in the SCC groups. Compared to patients with normal cervix tissue, the percentage of patients who were HPV positive and were diagnosed with CINII+ by TCT was significantly higher. FOXO1 expression was significantly higher in CIN tissue, but TGFBR2 and CTBP2 expression was significantly lower in CIN tissue. The significantly different genes and clinical factors were included in the models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Combination of clinical and significant genes to establish the random forest models can provide references to predict the occurrence and progression of CIN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-020-07265-7","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T06:04:21Z","timestamp":1601359461000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5888-0974","authenticated-orcid":false,"given":"Mengjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2209-9550","authenticated-orcid":false,"given":"He","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2553-9718","authenticated-orcid":false,"given":"Yuejuan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9376-7857","authenticated-orcid":false,"given":"Mingmiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7887-5286","authenticated-orcid":false,"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"issue":"2","key":"7265_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87\u2013108.","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"7265_CR2","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/jnci\/87.18.1365","volume":"87","author":"GY Ho","year":"1995","unstructured":"Ho GY, Burk RD, Klein S, Kadish AS, Chang CJ, Palan P, Basu J, Tachezy R, Lewis R, Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995;87(18):1365\u201371.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"7265_CR3","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","volume":"11","author":"S de Sanjose","year":"2010","unstructured":"de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048\u201356.","journal-title":"Lancet Oncol"},{"issue":"12","key":"7265_CR4","first-page":"5667","volume":"11","author":"Y Jiang","year":"2018","unstructured":"Jiang Y, Yin F, Chen Y, Yue L, Li L. Discovery of microarray-identified genes associated with the progression of cervical intraepithelial neoplasia. Int J Clin Exp Pathol. 2018;11(12):5667\u201381.","journal-title":"Int J Clin Exp Pathol"},{"key":"7265_CR5","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.5285","volume":"6","author":"MS Tan","year":"2018","unstructured":"Tan MS, Chang SW, Cheah PL, Yap HJ. Integrative machine learning analysis of multiple gene expression profiles in cervical cancer. PeerJ. 2018;6:e5285.","journal-title":"PeerJ"},{"issue":"3","key":"7265_CR6","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ygyno.2007.11.024","volume":"108","author":"P Biewenga","year":"2008","unstructured":"Biewenga P, Buist MR, Moerland PD. Ver Loren van Themaat E, van Kampen AH, ten Kate FJ, baas F: gene expression in early stage cervical cancer. Gynecol Oncol. 2008;108(3):520\u20136.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7265_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.virol.2009.10.011","volume":"396","author":"H Lichtig","year":"2010","unstructured":"Lichtig H, Gilboa DA, Jackman A, Gonen P, Levav-Cohen Y, Haupt Y, Sherman L. HPV16 E6 augments Wnt signaling in an E6AP-dependent manner. Virology. 2010;396(1):47\u201358.","journal-title":"Virology"},{"issue":"5","key":"7265_CR8","first-page":"1219","volume":"10","author":"K Okino","year":"2003","unstructured":"Okino K, Nagai H, Hatta M, Nagahata T, Yoneyama K, Ohta Y, Jin E, Kawanami O, Araki T, Emi M. Up-regulation and overproduction of DVL-1, the human counterpart of the Drosophila dishevelled gene, in cervical squamous cell carcinoma. Oncol Rep. 2003;10(5):1219\u201323.","journal-title":"Oncol Rep"},{"issue":"33","key":"7265_CR9","doi-asserted-by":"publisher","first-page":"3896","DOI":"10.1038\/onc.2012.380","volume":"32","author":"L Barroilhet","year":"2013","unstructured":"Barroilhet L, Yang J, Hasselblatt K, Paranal RM, Ng SK, Rauh-Hain JA, Welch WR, Bradner JE, Berkowitz RS, Ng SW. C-terminal binding protein-2 regulates response of epithelial ovarian cancer cells to histone deacetylase inhibitors. Oncogene. 2013;32(33):3896\u2013903.","journal-title":"Oncogene"},{"issue":"11","key":"7265_CR10","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1158\/0008-5472.CAN-06-0499","volume":"66","author":"CW Menges","year":"2006","unstructured":"Menges CW, Baglia LA, Lapoint R, McCance DJ. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 2006;66(11):5555\u20139.","journal-title":"Cancer Res"},{"issue":"11","key":"7265_CR11","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.15252\/emmm.201404976","volume":"7","author":"C He","year":"2015","unstructured":"He C, Mao D, Hua G, Lv X, Chen X, Angeletti PC, Dong J, Remmenga SW, Rodabaugh KJ, Zhou J, et al. The hippo\/YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression. EMBO molecular medicine. 2015;7(11):1426\u201349.","journal-title":"EMBO molecular medicine"},{"issue":"10","key":"7265_CR12","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1016\/j.celrep.2019.02.004","volume":"26","author":"C He","year":"2019","unstructured":"He C, Lv X, Huang C, Angeletti PC, Hua G, Dong J, Zhou J, Wang Z, Ma B, Chen X, et al. A Human Papillomavirus-Independent Cervical Cancer Animal Model Reveals Unconventional Mechanisms of Cervical Carcinogenesis. Cell Rep. 2019;26(10):2636\u20132650.e2635.","journal-title":"Cell Rep"},{"issue":"4","key":"7265_CR13","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1002\/1096-9896(200012)192:4<494::AID-PATH760>3.0.CO;2-W","volume":"192","author":"AM El-Sherif","year":"2000","unstructured":"El-Sherif AM, Seth R, Tighe PJ, Jenkins D. Decreased synthesis and expression of TGF-beta1, beta2, and beta3 in epithelium of HPV 16-positive cervical precancer: a study by microdissection, quantitative RT-PCR, and immunocytochemistry. J Pathol. 2000;192(4):494\u2013501.","journal-title":"J Pathol"},{"key":"7265_CR14","doi-asserted-by":"publisher","first-page":"41670","DOI":"10.1038\/srep41670","volume":"7","author":"H Yang","year":"2017","unstructured":"Yang H, Zhang H, Zhong Y, Wang Q, Yang L, Kang H, Gao X, Yu H, Xie C, Zhou F, et al. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer. Sci Rep. 2017;7:41670.","journal-title":"Sci Rep"},{"issue":"1","key":"7265_CR15","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s12885-019-5992-7","volume":"19","author":"KH Kim","year":"2019","unstructured":"Kim KH, Chung C, Kim JM, Lee D, Cho SY, Lee TH, Cho HJ, Yeo MK. Clinical significance of atypical protein kinase C (PKCiota and PKCzeta) and its relationship with yes-associated protein in lung adenocarcinoma. BMC Cancer. 2019;19(1):804.","journal-title":"BMC Cancer"},{"issue":"11","key":"7265_CR16","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gad.296640.117","volume":"31","author":"S Sarkar","year":"2017","unstructured":"Sarkar S, Bristow CA, Dey P, Rai K, Perets R, Ramirez-Cardenas A, Malasi S, Huang-Hobbs E, Haemmerle M, Wu SY, et al. PRKCI promotes immune suppression in ovarian cancer. Genes Dev. 2017;31(11):1109\u201321.","journal-title":"Genes Dev"},{"issue":"1","key":"7265_CR17","first-page":"28","volume":"12","author":"Femi OF","year":"2018","unstructured":"Femi OF. Genetic alterations and PIK3CA gene mutations and amplifications analysis in cervical cancer by racial groups in the United States. Int J Health Sci. 2018;12(1):28\u201332.","journal-title":"Int J Health Sci"},{"issue":"41","key":"7265_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000012792","volume":"97","author":"JY Chen","year":"2018","unstructured":"Chen JY, Wang ZL, Wang ZY, Yang XS. The risk factors of residual lesions and recurrence of the high-grade cervical intraepithelial lesions (HSIL) patients with positive-margin after conization. Medicine. 2018;97(41):e12792.","journal-title":"Medicine"},{"issue":"12","key":"7265_CR19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/apm.12064","volume":"121","author":"RB Simoes","year":"2013","unstructured":"Simoes RB, Campaner AB. Post-cervical conization outcomes in patients with high-grade intraepithelial lesions. APMIS. 2013;121(12):1153\u201361.","journal-title":"APMIS"},{"issue":"1","key":"7265_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12885-017-3425-z","volume":"17","author":"M Berraho","year":"2017","unstructured":"Berraho M, Amarti-Riffi A, El-Mzibri M, Bezad R, Benjaafar N, Benideer A, Matar N, Qmichou Z, Abda N, Attaleb M, et al. HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study. BMC Cancer. 2017;17(1):435.","journal-title":"BMC Cancer"},{"issue":"9312","key":"7265_CR21","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/S0140-6736(02)08151-5","volume":"359","author":"N Munoz","year":"2002","unstructured":"Munoz N, Franceschi S, Bosetti C, Moreno V, Herrero R, Smith JS, Shah KV, Meijer CJ, Bosch FX. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case-control study. Lancet. 2002;359(9312):1093\u2013101.","journal-title":"Lancet"},{"issue":"8","key":"7265_CR22","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2886","volume":"10","author":"CA Moody","year":"2010","unstructured":"Moody CA, Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer. 2010;10(8):550\u201360.","journal-title":"Nat Rev Cancer"},{"issue":"9916","key":"7265_CR23","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","volume":"383","author":"G Ronco","year":"2014","unstructured":"Ronco G, Dillner J, Elfstrom KM, Tunesi S, Snijders PJ, Arbyn M, Kitchener H, Segnan N, Gilham C, Giorgi-Rossi P, et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials. Lancet. 2014;383(9916):524\u201332.","journal-title":"Lancet"},{"issue":"4","key":"7265_CR24","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.31557\/APJCP.2019.20.4.1019","volume":"20","author":"AV dos Santos","year":"2019","unstructured":"dos Santos AV, dos Santos GT, Brackmann RL, Prolla JC, Bica CG. Follow-up of women with cervical cytological abnormalities: progression and regression events. Asian Pac J Cancer Prev. 2019;20(4):1019\u201324.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"7265_CR25","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41598-018-24882-2","volume":"8","author":"C Bekos","year":"2018","unstructured":"Bekos C, Schwameis R, Heinze G, Garner M, Grimm C, Joura E, Horvat R, Polterauer S, Polterauer M. Influence of age on histologic outcome of cervical intraepithelial neoplasia during observational management: results from large cohort, systematic review, meta-analysis. Sci Rep. 2018;8(1):6383.","journal-title":"Sci Rep"},{"issue":"1","key":"7265_CR26","first-page":"46","volume":"29","author":"G Ozgun","year":"2013","unstructured":"Ozgun G, Aydogdu G. Distribution of uterin cervical lesions and relation between age and parity rates in the Mardin province. Turk Patoloji Dergisi. 2013;29(1):46\u201350.","journal-title":"Turk Patoloji Dergisi"},{"issue":"1","key":"7265_CR27","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/bjc.2012.513","volume":"108","author":"KE Jensen","year":"2013","unstructured":"Jensen KE, Schmiedel S, Norrild B, Frederiksen K, Iftner T, Kjaer SK. Parity as a cofactor for high-grade cervical disease among women with persistent human papillomavirus infection: a 13-year follow-up. Br J Cancer. 2013;108(1):234\u20139.","journal-title":"Br J Cancer"},{"issue":"10","key":"7265_CR28","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1002\/dc.20516","volume":"34","author":"JS Misra","year":"2006","unstructured":"Misra JS, Das V, Srivastava AN, Singh U. Role of different etiological factors in progression of cervical intraepithelial neoplasia. Diagn Cytopathol. 2006;34(10):682\u20135.","journal-title":"Diagn Cytopathol"},{"key":"7265_CR29","doi-asserted-by":"crossref","unstructured":"Ito K, Kimura R, Konishi H, Ozawa N, Yaegashi N, Ohashi Y, Suzuki M, Kakizoe T. A comparison of liquid-based and conventional cytology using data for cervical cancer screening from the Japan Cancer society. Jpn J Clin Oncol. 2019.","DOI":"10.1093\/jjco\/hyz161"},{"issue":"3","key":"7265_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ygyno.2019.12.027","volume":"156","author":"SY Hu","year":"2020","unstructured":"Hu SY, Rezhake R, Chen F, Zhang X, Pan QJ, Ma JF, Qiao YL, Zhao FH. Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: a 15-year population-based cohort study from China. Gynecol Oncol. 2020;156(3):616\u201323.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"7265_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13045-017-0529-5","volume":"10","author":"S Manni","year":"2017","unstructured":"Manni S, Carrino M, Piazza F. Role of protein kinases CK1alpha and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways. J Hematol Oncol. 2017;10(1):157.","journal-title":"J Hematol Oncol"},{"key":"7265_CR32","doi-asserted-by":"crossref","unstructured":"Lebensohn AM, Dubey R, Neitzel LR, Tacchelly-Benites O, Yang E, Marceau CD, Davis EM, Patel BB, Bahrami-Nejad Z, Travaglini KJ, et al. Comparative genetic screens in human cells reveal new regulatory mechanisms in WNT signaling. eLife. 2016;5.","DOI":"10.7554\/eLife.21459"},{"issue":"57","key":"7265_CR33","doi-asserted-by":"publisher","first-page":"96482","DOI":"10.18632\/oncotarget.19946","volume":"8","author":"TY Tsang","year":"2017","unstructured":"Tsang TY, Wei W, Itamochi H, Tambouret R, Birrer MJ. Integrated genomic analysis of clear cell ovarian cancers identified PRKCI as a potential therapeutic target. Oncotarget. 2017;8(57):96482\u201395.","journal-title":"Oncotarget"},{"issue":"6","key":"7265_CR34","doi-asserted-by":"publisher","first-page":"888","DOI":"10.4149\/neo_2018_171220N828","volume":"65","author":"DP Wang","year":"2018","unstructured":"Wang DP, Gu LL, Xue Q, Chen H, Mao GX. CtBP2 promotes proliferation and reduces drug sensitivity in non-small cell lung cancer via the Wnt\/beta-catenin pathway. Neoplasma. 2018;65(6):888\u201397.","journal-title":"Neoplasma"},{"issue":"2","key":"7265_CR35","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.3892\/or.2017.5763","volume":"38","author":"Q Xuan","year":"2017","unstructured":"Xuan Q, Zhong X, Li W, Mo Z, Huang Y, Hu Y. CtBP2 is associated with angiogenesis and regulates the apoptosis of prostate cancer cells. Oncol Rep. 2017;38(2):1259\u201367.","journal-title":"Oncol Rep"},{"issue":"13","key":"7265_CR36","doi-asserted-by":"publisher","first-page":"9028","DOI":"10.1074\/jbc.M112.432005","volume":"288","author":"Y Wang","year":"2013","unstructured":"Wang Y, Liu F, Mao F, Hang Q, Huang X, He S, Wang Y, Cheng C, Wang H, Xu G, et al. Interaction with cyclin H\/cyclin-dependent kinase 7 (CCNH\/CDK7) stabilizes C-terminal binding protein 2 (CtBP2) and promotes cancer cell migration. J Biol Chem. 2013;288(13):9028\u201334.","journal-title":"J Biol Chem"},{"issue":"2","key":"7265_CR37","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.virol.2013.05.018","volume":"443","author":"T Subramanian","year":"2013","unstructured":"Subramanian T, Zhao LJ, Chinnadurai G. Interaction of CtBP with adenovirus E1A suppresses immortalization of primary epithelial cells and enhances virus replication during productive infection. Virology. 2013;443(2):313\u201320.","journal-title":"Virology"},{"issue":"7","key":"7265_CR38","first-page":"1899","volume":"22","author":"N Cai","year":"2018","unstructured":"Cai N, Hu L, Xie Y, Gao JH, Zhai W, Wang L, Jin QJ, Qin CY, Qiang R. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-beta receptor 2. Eur Rev Med Pharmacol Sci. 2018;22(7):1899\u2013906.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"2","key":"7265_CR39","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/path.2785","volume":"223","author":"E Meulmeester","year":"2011","unstructured":"Meulmeester E, Ten Dijke P. The dynamic roles of TGF-beta in cancer. J Pathol. 2011;223(2):205\u201318.","journal-title":"J Pathol"},{"issue":"6","key":"7265_CR40","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1093\/carcin\/bgu050","volume":"35","author":"H Xu","year":"2014","unstructured":"Xu H, Zhang Y, Altomare D, Pena MM, Wan F, Pirisi L, Creek KE. Six1 promotes epithelial-mesenchymal transition and malignant conversion in human papillomavirus type 16-immortalized human keratinocytes. Carcinogenesis. 2014;35(6):1379\u201388.","journal-title":"Carcinogenesis"},{"issue":"2","key":"7265_CR41","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.4238\/2015.June.18.3","volume":"14","author":"B Zhang","year":"2015","unstructured":"Zhang B, Gui LS, Zhao XL, Zhu LL, Li QW. FOXO1 is a tumor suppressor in cervical cancer. Gene Mol Res. 2015;14(2):6605\u201316.","journal-title":"Gene Mol Res"},{"issue":"8","key":"7265_CR42","first-page":"2253","volume":"22","author":"A Aishanjiang","year":"2018","unstructured":"Aishanjiang A, Rouzi N, Jiao Z, Wang L, Wusainahong K, Wumanjiang N, Musha M, Niyazi M. MicroRNA-9 enhances invasion and migration of cervical carcinomas by directly targeting FOXO1. Eur Rev Med Pharmacol Sci. 2018;22(8):2253\u201360.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"7265_CR43","first-page":"10294","volume":"8","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhao S, Cui M, Wang Q. Down-regulation of microRNA-135b inhibited growth of cervical cancer cells by targeting FOXO1. Int J Clin Exp Pathol. 2015;8(9):10294\u2013304.","journal-title":"Int J Clin Exp Pathol"},{"issue":"11","key":"7265_CR44","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s10147-019-01507-w","volume":"24","author":"DB Chay","year":"2019","unstructured":"Chay DB, Han GH, Nam S, Cho H, Chung JY, Hewitt SM. Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer. Int J Clin Oncol. 2019;24(11):1429\u201339.","journal-title":"Int J Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07265-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-020-07265-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-07265-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:54:25Z","timestamp":1632858865000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-07265-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["7265"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-07265-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-33710\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33710\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-33710\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"4 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures performed in studies involving human participants were approved by the Ethics Committee of Guangxi Medical University affiliated Cancer Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Mengjie Chen declares that she has no conflict of interest. He Wang declares that she has no conflict of interest. Yuejuan Liang declares that she has no conflict of interest. Mingmiao Hu declares that she has no conflict of interest. Li Li declares that she has no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"926"}}